Anti-IFN-α/-ω neutralizing antibodies from COVID-19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity.

Eur J Immunol · 2022 · PMC9087404 · PMID 35419822

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

A nonsignificant trend was observed in patients with anti‐IFN‐I NAB compared to those negative for anti‐IFN‐I BAB for a reduction in lymphocytes (Panel I) and monocytes (Panel L) (Fig. 2 ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.